-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PF-08046050 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PF-08046050 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PF-08046050 in Gastric Cancer Drug Details: PF-08046050 is under development for...
-
Product Insights
NewRadiopharm Theranostics Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Radiopharm Theranostics Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Radiopharm Theranostics Ltd (Radiopharm Theranostics) develops a platform for radiopharmaceutical and nuclear medicine products for both diagnostic and therapeutic uses. The company uses its technologies including Nano-mAbs, Nano-mAbs, AVß6 Integrin, PSA-mAb, a radiopharmaceuticals platform for treating oncological diseases, HER-2, TROP-2, PD-L1. It is developing pipeline products that are in the clinical development stage including RAD101, RAD102, RAD202, RAD204, RAD301,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zolbetuximab in Metastatic Adenocarcinoma of The Pancreas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zolbetuximab in Metastatic Adenocarcinoma of The Pancreas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zolbetuximab in Metastatic Adenocarcinoma of The Pancreas Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ETx-01 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ETx-01 in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ETx-01 in Ovarian Cancer Drug Details: ETx-01 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ETx-01 in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ETx-01 in Prostate Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ETx-01 in Prostate Cancer Drug Details: ETx-01 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ETx-01 in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ETx-01 in Cervical Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ETx-01 in Cervical Cancer Drug Details: ETx-01 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ETx-01 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ETx-01 in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ETx-01 in Pancreatic Cancer Drug Details: ETx-01 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ETx-01 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ETx-01 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ETx-01 in Solid Tumor Drug Details: ETx-01 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ETx-01 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ETx-01 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ETx-01 in Non-Small Cell Lung Cancer Drug Details: ETx-01...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ETx-01 in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ETx-01 in Fallopian Tube Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ETx-01 in Fallopian Tube Cancer Drug Details: ETx-01 is under...